These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8879332)
21. A dose of pharmaco-economics. Can health networks learn from the drug policies of managed care plans? Taylor KS; Hagland MM Hosp Health Netw; 1993 Jul; 67(13):33-6. PubMed ID: 8513368 [No Abstract] [Full Text] [Related]
22. User applications of health economics data. Navarro RP Med Interface; 1996 Mar; 9(3):81-2. PubMed ID: 10156017 [No Abstract] [Full Text] [Related]
23. A managed care timeline, 1988-1996. Bell N Med Interface; 1997 Jan; 10(1):66-72, 75-80. PubMed ID: 10164507 [No Abstract] [Full Text] [Related]
24. Health costs: why employers won another round. Findlay S; Meyeroff WJ Bus Health; 1996 Mar; 14(3):49-51. PubMed ID: 10156387 [No Abstract] [Full Text] [Related]
25. Survey. Managed-care organizations on the rebound. Kenkel PJ Mod Healthc; 1990 May; 20(20):82, 84-6, 88. PubMed ID: 10104883 [TBL] [Abstract][Full Text] [Related]
26. Data watch. Managed care penetration differs by market. Hospitals; 1993 Mar; 67(6):67. PubMed ID: 8444462 [No Abstract] [Full Text] [Related]
27. Facing the next challenge of pharmaceutical care: patient noncompliance. Bloom DL Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562 [TBL] [Abstract][Full Text] [Related]
28. Health economics in drug therapy management. Navarro RP Med Interface; 1995 May; 8(5):127-8, 130. PubMed ID: 10142785 [No Abstract] [Full Text] [Related]
29. Stats & facts. More consumer cost sharing in pharmacy benefit. Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701 [No Abstract] [Full Text] [Related]
30. An industry in evolution. Blissenbach HF Med Interface; 1995 Oct; 8(10):80-1, 88. PubMed ID: 10152328 [No Abstract] [Full Text] [Related]
31. Raising their voice. Group's message: managed care means more than HMOs. Kertesz L Mod Healthc; 1997 Nov; 27(45):118. PubMed ID: 10174157 [No Abstract] [Full Text] [Related]
32. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements. Penm J; Chaar B; Dechun J; Moles R Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603 [TBL] [Abstract][Full Text] [Related]
33. Which PPOs will take the biggest bite out of fees? Med Econ; 1990 Jun; 67(11):118. PubMed ID: 10105007 [No Abstract] [Full Text] [Related]
34. The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information. Fijn R; de Vries CS; Engels SA; Brouwers JR; de Blaey CJ; de Jong-van den Berg LT Pharm World Sci; 1999 Jun; 21(3):120-6. PubMed ID: 10427581 [TBL] [Abstract][Full Text] [Related]
35. Provider-based managed-care plans continue growth trend. Annual survey shows HMOs and PPOs are healthy, well-prepared to play starring role in reform. Kenkel PJ Mod Healthc; 1993 May; 23(19):26-8, 30, 32-4. PubMed ID: 10125879 [No Abstract] [Full Text] [Related]
36. The effect of the Medicare Part D benefit on medication management. Pezalla E Manag Care Interface; 2007 Jul; 20(7):13, 15. PubMed ID: 17849727 [No Abstract] [Full Text] [Related]
37. The issue of noncompliance. Navarro RP Med Interface; 1996 Aug; 9(8):70, 72. PubMed ID: 10159579 [No Abstract] [Full Text] [Related]
38. Managed care organizations. Shoor R State Health Care Am; 1994; ():28-30, 32-5. PubMed ID: 10133846 [TBL] [Abstract][Full Text] [Related]